Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
OCUL
OCUL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
OCUL News
AXPAXLI Demonstrates Unmatched Durability in Wet AMD Treatment
Apr 13 2026
Newsfilter
Ocular Therapeutix Shares Surge 10.45% Ahead of Key Conferences
Apr 10 2026
Yahoo Finance
Ocular Therapeutix to Participate in Multiple Scientific Conferences
Apr 01 2026
Newsfilter
EyePoint Sues Ocular for False Claims on Duravyu
Mar 21 2026
seekingalpha
VR Adviser, LLC Reduces Stake in Ocular Therapeutix
Mar 18 2026
Fool
VR Adviser, LLC Sells Shares of Ocular Therapeutix
Mar 18 2026
NASDAQ.COM
Wall Street Analysts Adjust GE Stock Ratings
Mar 03 2026
Benzinga
OCUL Stock 52-Week High and Low Analysis
Mar 02 2026
NASDAQ.COM
Ocular Therapeutix Shares Drop Amid Inflation Concerns
Feb 28 2026
Yahoo Finance
Analysis of Potential and Risks in Small-Cap Stocks
Feb 27 2026
Yahoo Finance
iShares Expanded Tech-Software ETF Underperforms
Feb 23 2026
NASDAQ.COM
Ocular Therapeutix to Present AXPAXLI Trial Results at Macula Society Meeting
Feb 23 2026
NASDAQ.COM
Investigation into Ocular Therapeutix Investor Claims
Feb 18 2026
Globenewswire
U.S. Stocks Mostly Lower, Nasdaq Drops Over 50 Points
Feb 17 2026
Benzinga
Ocular Therapeutix Shares Drop Following Axpaxli Trial Data Disappointment
Feb 17 2026
Benzinga
OCULAR THERAPEUTIX STOCK PLUMMETS 23.5% FOLLOWING RELEASE OF LATE-STAGE EYE DISEASE TRIAL RESULTS
Feb 17 2026
moomoo
Show More News
